SCHEMBL3320910

SCHEMBL3320910

COc1ccc(-c2cc(=O)c3c(O)c(C)c(O)c(C)c3o2)cc1OC

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.70
▸ MAPT P10636 3/20 0.70
▸ CYP3A4 P08684 2/20 0.70
▸ MAPK1 P28482 2/20 0.70
▸ USP2 O75604 1/20 0.70
▸ LMNA P02545 1/20 0.70
▸ ELANE P08246 1/20 0.70
▸ MEN1 O00255 3/20 0.62
▸ KMT2A Q03164 3/20 0.62
▸ KDM4E B2RXH2 2/20 0.62
▸ ABCB1 P08183 2/20 0.62
▸ ABCG2 Q9UNQ0 2/20 0.62
▸ HPGD P15428 1/20 0.62
▸ HSD17B10 Q99714 1/20 0.62
▸ TERT O14746 1/20 0.61
▸ CYP1B1 Q16678 3/20 0.60
▸ CYP1A1 P04798 2/20 0.60
▸ CYP1A2 P05177 2/20 0.60
▸ POLB P06746 1/20 0.60
▸ GAA P10253 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30956242 1.00 ALDH1A1 (0.70) ALDH1A1MAPTCYP3A4MAPK1USP2
SCHEMBL4310257 0.88 ALDH1A1 (0.61) ALDH1A1MAPTCYP3A4MAPK1USP2
SCHEMBL1764664 0.85 ALDH1A1 (0.86) ALDH1A1MAPTCYP3A4MAPK1USP2
5-Demethylnobiletin SCHEMBL31237479 0.82 ALDH1A1 (1.00) ALDH1A1MAPTCYP3A4MAPK1USP2
5-Demethylnobiletin SCHEMBL1764120 0.82 ALDH1A1 (1.00) ALDH1A1MAPTCYP3A4MAPK1USP2
5-Demethylnobiletin SCHEMBL29606981 0.82 ALDH1A1 (1.00) ALDH1A1MAPTCYP3A4MAPK1USP2
SCHEMBL17963714 0.82 ALDH1A1 (0.91) ALDH1A1MAPTCYP3A4MAPK1USP2
SCHEMBL28009934 0.82 TERT (0.58) ALDH1A1MAPTCYP3A4MAPK1LMNA
SCHEMBL16088300 0.81 HDAC6 (0.78) ALDH1A1MAPTCYP3A4MAPK1USP2
SCHEMBL29615754 0.81 KMT2A (0.68) ALDH1A1MAPTCYP3A4MAPK1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118191079-A Mass spectrum imaging method for saponins and lipid components in ginseng root and application thereof 天津中医药大学 2024-06-14 — — CN disclosed
US-20100120902-A1 STANDARIZED BIOACTIVE HERBAL EXTRACTS RANBAXY LABORATORIES LIMITED (IN) 2010-05-13 — — US disclosed
EP-2139504-A1 STANDARDIZED BIOACTIVE HERBAL EXTRACTS Ranbaxy Laboratories Limited (IN) 2010-01-06 — — EP disclosed
WO-2008117230-A1 STANDARDIZED BIOACTIVE HERBAL EXTRACTS RANBAXY LABORATORIES LIMITED (IN) 2008-10-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120902-A1 STANDARIZED BIOACTIVE HERBAL EXTRACTS CPA3, S100P, DKK1 ALDH1A1 2498/4885MAPT 4182/4885CYP3A4 1556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback